Clinical features of patients
Patient . | Age/sex . | Diagnosis . | Neutrophils, 103/mm3 . | Reticulocytes, 103/mm3 . | Platelets, 103/mm3 . |
---|---|---|---|---|---|
1 | 22/F | MAA | 0.903 | 31.3 | 65 |
2 | 9/F | SAA | 0.803 | 58.1 | 111 |
3 | 16/M | SAA | 0.152 | 22.7 | 5 |
4 | 23/M | SAA | 0.296 | 31.9 | 36 |
5 | 30/M | SAA | 0.041 | 9.3 | 25 |
6 | 26/M | MAA | 0.802 | 29.2 | 21 |
7 | 69/M | SAA | 0.390 | 17.2 | 54 |
8 | 45/F | SAA | 1.116 | 15.8 | 13 |
9 | 25/F | MAA | 2.550 | 83.8 | 136 |
10 | 66/M | MAA | 1.341 | 72.7 | 51 |
11 | 22/M | MAA | 0.788 | 55.0 | 48 |
12 | 42/M | SAA | 0.802 | 25.0 | 22 |
13 | 22/F | SAA | 0.903 | 31.3 | 49 |
14 | 17/F | SAA | 0.058 | 3.1 | 58 |
15 | 21/M | SAA | 0.885 | 72.9 | 8 |
16 | 50/M | SAA | 0.315 | 16.6 | 8 |
17 | 33/F | MAA | 2.486 | 46.3 | 239 |
18 | 68/M | SAA | 0.461 | 16.2 | 24 |
19 | 28/F | SAA | 0.620 | 22.9 | 44 |
20 | 19/M | SAA | NA | 41.3 | 27 |
21 | 30/M | SAA | 0.014 | 2.7 | 21 |
22 | 51/M | SAA | 0.024 | 2.6 | 1 |
23 | 11/F | SAA | 0.431 | 50.2 | 13 |
24 | 28/F | SAA | 1.131 | 15.5 | 8 |
25 | 55/F | SAA | 0.650 | 7.1 | 53 |
26 | 40/F | MAA | 3.050 | 72.3 | 23 |
27 | 37/M | MAA | 2.010 | 39.3 | 35 |
28 | 74/M | SAA | NA | 31.4 | 8 |
29 | 48/M | SAA | 0.180 | 8.0 | 13 |
30 | 65/M | SAA | 0.790 | 21.1 | 25 |
31 | 27/M | SAA | 0.050 | 3.5 | 34 |
32 | 82/M | SAA | 0.220 | 18.2 | 25 |
33 | 17/F | MAA | 1.930 | 35.3 | 57 |
34 | 66/M | SAA | 3.350 | 0.7 | 38 |
35 | 57/M | MAA | 1.190 | 56.4 | 124 |
36 | 56/F | SAA | 0.090 | 50.2 | 84 |
Patient . | Age/sex . | Diagnosis . | Neutrophils, 103/mm3 . | Reticulocytes, 103/mm3 . | Platelets, 103/mm3 . |
---|---|---|---|---|---|
1 | 22/F | MAA | 0.903 | 31.3 | 65 |
2 | 9/F | SAA | 0.803 | 58.1 | 111 |
3 | 16/M | SAA | 0.152 | 22.7 | 5 |
4 | 23/M | SAA | 0.296 | 31.9 | 36 |
5 | 30/M | SAA | 0.041 | 9.3 | 25 |
6 | 26/M | MAA | 0.802 | 29.2 | 21 |
7 | 69/M | SAA | 0.390 | 17.2 | 54 |
8 | 45/F | SAA | 1.116 | 15.8 | 13 |
9 | 25/F | MAA | 2.550 | 83.8 | 136 |
10 | 66/M | MAA | 1.341 | 72.7 | 51 |
11 | 22/M | MAA | 0.788 | 55.0 | 48 |
12 | 42/M | SAA | 0.802 | 25.0 | 22 |
13 | 22/F | SAA | 0.903 | 31.3 | 49 |
14 | 17/F | SAA | 0.058 | 3.1 | 58 |
15 | 21/M | SAA | 0.885 | 72.9 | 8 |
16 | 50/M | SAA | 0.315 | 16.6 | 8 |
17 | 33/F | MAA | 2.486 | 46.3 | 239 |
18 | 68/M | SAA | 0.461 | 16.2 | 24 |
19 | 28/F | SAA | 0.620 | 22.9 | 44 |
20 | 19/M | SAA | NA | 41.3 | 27 |
21 | 30/M | SAA | 0.014 | 2.7 | 21 |
22 | 51/M | SAA | 0.024 | 2.6 | 1 |
23 | 11/F | SAA | 0.431 | 50.2 | 13 |
24 | 28/F | SAA | 1.131 | 15.5 | 8 |
25 | 55/F | SAA | 0.650 | 7.1 | 53 |
26 | 40/F | MAA | 3.050 | 72.3 | 23 |
27 | 37/M | MAA | 2.010 | 39.3 | 35 |
28 | 74/M | SAA | NA | 31.4 | 8 |
29 | 48/M | SAA | 0.180 | 8.0 | 13 |
30 | 65/M | SAA | 0.790 | 21.1 | 25 |
31 | 27/M | SAA | 0.050 | 3.5 | 34 |
32 | 82/M | SAA | 0.220 | 18.2 | 25 |
33 | 17/F | MAA | 1.930 | 35.3 | 57 |
34 | 66/M | SAA | 3.350 | 0.7 | 38 |
35 | 57/M | MAA | 1.190 | 56.4 | 124 |
36 | 56/F | SAA | 0.090 | 50.2 | 84 |
All patients received new diagnoses, but had not been treated. MAA indicates moderate AA; SAA, severe AA; NA, not available.